Amundi Asset Management US’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,940
Closed -$314K 1587
2020
Q4
$314K Hold
10,940
﹤0.01% 1371
2020
Q3
$267K Buy
10,940
+10,900
+27,250% +$235K ﹤0.01% 1346
2020
Q2
$1K Hold
40
﹤0.01% 1603
2020
Q1
$0 Hold
40
﹤0.01% 1683
2019
Q4
$1K Sell
40
-34,302
-100% -$415K ﹤0.01% 1596
2019
Q3
$408K Buy
34,342
+30,342
+759% +$562K ﹤0.01% 1350
2019
Q2
$99K Sell
4,000
-33
-0.8% -$951 ﹤0.01% 1577
2019
Q1
$129K Buy
+4,033
New +$143K ﹤0.01% 1518

Other funds holding CVET

Amundi Asset Management US's CVET Position: Q1 2021 in Review

Amundi Asset Management US sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2021, closing a stake of 10,940 shares — an estimated $314K sold.

Amundi Asset Management US first reported a position in CVET in Q1 2019 and held it in 8 quarters. The position peaked at $408K in Q3 2019. 273 funds tracked by Wall St. Rank hold CVET as of Q1 2021.

  • Amundi Asset Management US reported no remaining Covetrus, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Amundi Asset Management US sold 10,940 Covetrus, Inc. Common Stock shares in Q1 2021, an estimated $314K.
  • Amundi Asset Management US first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 8 quarters.
  • Amundi Asset Management US's Covetrus, Inc. Common Stock position peaked at $408K in Q3 2019.
  • 273 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.